AAAAAA

   
Results: 1-17 |
Results: 17
Cytokine and chemokine dysregulation in hyper-IgE syndrome
Authors: Chehimi, J Elder, M Greene, J Noroski, L Stiehm, ER Winkelstein, JA Sullivan, KE
Citation: J. Chehimi et al., Cytokine and chemokine dysregulation in hyper-IgE syndrome, CLIN IMMUNO, 100(1), 2001, pp. 49-56
Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome
Authors: Davies, K Stiehm, ER Woo, P Murray, KJ
Citation: K. Davies et al., Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome, J RHEUMATOL, 28(10), 2001, pp. 2326-2334
Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies
Authors: Ziegner, UHM Ochs, HD Schanen, C Feig, SA Seyama, K Futatani, T Gross, T Wakim, M Roberts, RL Rawlings, DJ Dovat, S Fraser, JK Stiehm, ER
Citation: Uhm. Ziegner et al., Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies, J PEDIAT, 138(4), 2001, pp. 570-573
Shortage of IV immunoglobulin
Authors: Stiehm, ER
Citation: Er. Stiehm, Shortage of IV immunoglobulin, ANN ALLER A, 85(5), 2000, pp. 424-424
Passive immunity in prevention and treatment of infectious diseases
Authors: Keller, MA Stiehm, ER
Citation: Ma. Keller et Er. Stiehm, Passive immunity in prevention and treatment of infectious diseases, CLIN MICROB, 13(4), 2000, pp. 602
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine
Authors: Lambert, JS Watts, DH Mofenson, L Stiehm, ER Harris, DR Bethel, J Whitehouse, J Jimenez, E Gandia, J Scott, G O'Sullivan, MJ Kovacs, A Stek, A Shearer, WT Hammill, H van Dyke, R Maupin, R Silio, M Fowler, MG
Citation: Js. Lambert et al., Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine, AIDS, 14(10), 2000, pp. 1389-1399
Cytokine dysregulation in the hyperimmunoglobulinemia E syndrome
Authors: Stiehm, ER
Citation: Er. Stiehm, Cytokine dysregulation in the hyperimmunoglobulinemia E syndrome, J PEDIAT, 136(2), 2000, pp. 141-143
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
Authors: Stiehm, ER Fletcher, CV Mofenson, LM Palumbo, PE Kang, MH Fenton, T Sapan, CV Meyer, WA Shearer, WT Hawkins, E Fowler, MG Bouquin, P Purdue, L Sloand, EM Nemo, GJ Wara, D Bryson, YJ Starr, SE Petru, A Burchett, S
Citation: Er. Stiehm et al., Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273), J INFEC DIS, 181(2), 2000, pp. 548-554
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
Authors: Jabs, DA Rosenbaum, JT Foster, CS Holland, GN Jaffe, GJ Louie, JS Nussenblatt, RB Stiehm, ER Tessler, H Van Gelder, RN Whitcup, SM Yocum, D
Citation: Da. Jabs et al., Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel, AM J OPHTH, 130(4), 2000, pp. 492-513
Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of <= 500/mu L
Authors: Watts, DH Lambert, JS Stiehm, ER Bethel, J Whitehouse, J Fowler, MG Read, J
Citation: Dh. Watts et al., Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of <= 500/mu L, AM J OBST G, 183(1), 2000, pp. 100-107
Untitled
Authors: Shearer, WT Abramson, SL Adelman, DC Corn, B Cunningham-Rundles, C Kishiyama, JL Richmond, W Shames, RS Sperber, K Stiehm, ER Valacer, DJ
Citation: Wt. Shearer et al., Untitled, CLIN IMMUNO, 93(2), 1999, pp. 184-185
Growth hormone exerts potent anabolic effects in an adolescent with human immunodeficiency virus wasting
Authors: Dreimane, D Gallagher, K Nielsen, K Krogstad, P Stiehm, ER Bryson, YJ Geffner, ME
Citation: D. Dreimane et al., Growth hormone exerts potent anabolic effects in an adolescent with human immunodeficiency virus wasting, PEDIAT INF, 18(2), 1999, pp. 167-169
Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine
Authors: Dovat, S Roberts, RL Wakim, M Stiehm, ER Feig, SA
Citation: S. Dovat et al., Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine, BONE MAR TR, 24(3), 1999, pp. 321-323
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
Authors: Mofenson, LM Lambert, JS Stiehm, ER Bethel, J Meyer, WA Whitehouse, J Moye, J Reichelderfer, P Harris, DR Fowler, MG Mathieson, BJ Nemo, GJ
Citation: Lm. Mofenson et al., Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine, N ENG J MED, 341(6), 1999, pp. 385-393
Maternal viral load and the risk of perinatal transmission of HIV-1 - Reply
Authors: Mofenson, LM Lambert, JS Stiehm, ER
Citation: Lm. Mofenson et al., Maternal viral load and the risk of perinatal transmission of HIV-1 - Reply, N ENG J MED, 341(22), 1999, pp. 1699-1699
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185
Authors: Stiehm, ER Lambert, JS Mofenson, LM Bethel, J Whitehouse, J Nugent, R Moye, J Fowler, MG Mathieson, BJ Reichelderfer, P Nemo, GJ Korelitz, J Meyer, WA Sapan, CV Jimenez, E Gandia, J Scott, G O'Sullivan, MJ Kovacs, A Stek, A Shearer, WT Hammill, H
Citation: Er. Stiehm et al., Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185, J INFEC DIS, 179(3), 1999, pp. 567-575
Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis
Authors: Schuster, V Seidenspinner, S Zeitler, P Escher, C Pleyer, U Bernauer, W Stiehm, ER Isenberg, S Seregard, S Olsson, T Mingers, AM Schambeck, C Kreth, HW
Citation: V. Schuster et al., Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis, BLOOD, 93(10), 1999, pp. 3457-3466
Risultati: 1-17 |